StockGlow

Decoy Therapeutics Inc. (DCOY)

Designs peptide drugs to treat infections and cancer using AI-powered technology.

$4.12+0.10%Healthcare
Compare DCOY with
StockGlow Score
3
Bearish
BearishBullish
1 year ago-96.4%

The outlook

Decoy Therapeutics trades near its 52-week low with minimal upward movement today. The stock sits well below both its 50- and 200-day moving averages, and analyst coverage appears sparse or absent. Current data reflects a weak technical position with limited institutional enthusiasm.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$2.2M
52-wk high
$415.80
52-wk low
$3.57
50-day avg
$6.28
200-day avg
$12.14
Trailing P/E
0.0

Similar stocks

PHIOPhio Pharmaceuticals Corp.$1.02-2.87%PDSBPDS Biotechnology Corporation$0.69-0.87%SXTCChina SXT Pharmaceuticals, Inc.$0.05-26.07%ADILAdial Pharmaceuticals, Inc.$2.90+3.20%PSTVPlus Therapeutics, Inc.$3.70-0.79%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy